Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Epizyme, Inc.

TRADE

NASDAQ: EPZMHealthcare / Biotechnology / USA
9.38+0.13+1.41%Vol 961 5071Y Perf -47.18%
Oct 16th, 2018 16:00
BID9.03 ASK9.48
Open9.20 Previous Close9.25
Pre-Market9.25 After-Trading9.38
 - -%  - -%
Target Price
20.56 
Analyst Rating
Moderate Buy 1.60
Potencial %
119.19 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
100/100/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
100/100/100 
Growth Ranking
★★★+     55.86
Insiders Shares Cnt. % 3/6/12M
100/100/100 
Income Ranking
 —    -
Market Cap (mil)742 
Earnings Rating
Price Range Ratio 52wk %
6.02 
Earnings Date
7th Nov 2018

Today's Price Range

9.119.48

 

52wk Range

8.6121.40

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Buy
Performance
1 Month
-6.67%
3 Months
-31.03%
6 Months
-43.66%
1 Year
-47.18%
3 Years
-27.40%
5 Years
-74.58%

Quotes

Name / TickerPriceChg.Chg.%
EPZM9.380.13001.41
AAPL222.154.79002.20
GOOG1 121.2829.03002.66
MSFT111.003.40003.16
XOM81.200.38000.47
WFC53.730.49000.92
JNJ136.562.61001.95
FB158.785.26003.43
GE12.10-0.0500-0.41
JPM108.622.28002.14
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 7.40
Current Ratio 8.10
Long Term Debt to Total Capital 0.00
Total Debt to Equity 0.00
Interest Coverage -
Leverage Ratio 1.20
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-1 172.20
EBITDA Margin-1 160.50
Pre-tax Profit Margin-1 606.20
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 3.16
PS Ratios 54.13
Price to Cash Flow 30.20
Price to Free Cash Flow -6.90
Cash Flow Per Share -1.98
Price to Tangible Book3.16
Book Value per Share2.96
Enterprise Value (in ths.)433 959
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-60.92
ROE last 12 Months -76.29
Return on Assets (5Y Avg) -40.23
ROA last 12 Months -60.96
Return on Capital (5Y Avg) -51.21
ROC last 12 Months -76.92
Return on invested Capital Q -13.34
Return on invested Capital Y-61.36
Assets Turnover0.00
Receivables Turnover66.70
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)12 000
Revenue per Share 0.17
Revenue Growth 3 Years 24.89
Revenue Growth 5 Years -32.03
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 2018-0.53-0.4220.75
Q01 2018-0.54-0.499.26
Q04 2017-0.56-0.527.14
Q03 2017-0.65-0.633.08
Q02 2017-0.56-0.4814.29
Q01 2017-0.63-0.5611.11
Q04 2016-0.64-0.606.25
Q03 2016-0.56-0.4225.00
Earnings Per EndEstimateRevision %Trend
9/2018 QR-0.61-5.17Negative
12/2018 QR-0.61-3.39Negative
12/2018 FY-2.124.50Positive
12/2019 FY-2.151.83Positive
Next Report Date7th Nov 2018
Estimated EPS Next Report-0.61
Estimates Count8
EPS Growth Next 5 Years %-
Volume Overview
Volume961 507
Shares Outstanding (in ths.)79 130
Trades Count4 521
Dollar Volume8 309 962
Avg. Volume476 416
Avg. Weekly Volume751 576
Avg. Monthly Volume751 489
Avg. Quarterly Volume523 389

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

33%67%

Bearish Bullish

63%37%

Bearish Bullish

72%28%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
7 (70.00 %)
7 (77.78 %)
7 (77.78 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
3 (30.00 %)
2 (22.22 %)
2 (22.22 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
1.60
Strong Buy
1.44
Strong Buy
1.44

There are no comments yet.

News

x